Thyroid nodules are common, usually asymptomatic, and often pose minimal risk to the
affected patient. However, 10–15% prove malignant and serve as the rationale for …

Over the past several decades, the approach to the diagnosis and management of patients
with follicular cell‐derived thyroid cancer has evolved based on improved classification of …

Environmental factors are recognized as risk factors of thyroid cancer in humans. Exposure
to radiation, both from nuclear weapon or fallout or medical radiation, and to some organic …

Abstract The guidelines Thyroid Cancer 2022 are prepared based on previous Polish
recommendations updated in 2018. They consider international guidelines—American …

OBJECTIVE. The paradigm of theranostics is based on tailoring therapy for the purpose of
optimizing outcomes. This principle is being applied to radioactive iodine therapy …

The management of radioiodine refractory thyroid cancers (RAIR TC) is challenging for the
clinician. Tyrosine kinase inhibitors classically prescribed in this setting can fail due to …

Surgery—with or without postoperative radioiodine—is the standard of care for most patients
with differentiated thyroid carcinoma (DTC). Thyroid hormone replacement therapy is the …

An ever-increasing population of patients with papillary thyroid cancer is engaging with
health care systems around the world. Numerous questions about optimal management …

Background: Before the development of antithyroid drugs in the 1940s, treatment of Graves'
hyperthyroidism was primarily surgical. Surgical mortality was quite variable, but a …

Purpose Concern is growing about long-term side effects of differentiated thyroid cancer
treatment, most notably radioactive iodine (RAI) therapy. However, published studies on the …